← All trials
NCT00500409
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2005
- Primary completion
- Dec 1, 2006
- Completion date
- Jul 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 82
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Virchow GroupLead sponsor
- M.S. Ramaiah Medical College, Bangalore, IndiaOverall official - principal investigator
- Medwin Hospital, Hyderabad, AP, IndiaOverall official - principal investigator
- Apollo Hospitals, Chennai, IndiaOverall official - principal investigator
- P.D. Hinduja Hospital and Medical Research Centre, MumbaiOverall official - principal investigator
- Care Hospital, HyderabadOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.